Executive Summary

Oct 2019
PROSPECTS
Antifungals and haemorrhoid treatments losing their social stigma?

A number of dermatological products have traditionally been surrounded by social stigma, for example vaginal and topical antifungals or haemorrhoid treatments. However, it would seem the stigma attached to these products is gradually being eroded, with antifungals holding the largest value share within dermatologicals (combining topical and vaginal) and haemorrhoid treatments the most dynamic category in 2019.

Increasing diagnosis of skin diseases offers growth potential for dermatologicals

There is increasing diagnosis of skin diseases in Colombia, with experts stating that atopic dermatitis has become one of the diseases that most Colombians suffer from in terms of dermatological problems. It is estimated that between 5% and 10% of the Colombian population may be affected by this chronic condition.

Venezuelan immigrants provide a major new consumer base for products like nappy (diaper) rash treatments

Although the birth rate is declining in Colombia, it is still relatively high, standing at 14.4 births per 1,000 population in 2019.

COMPETITIVE LANDSCAPE
Dermatologicals led by foreign companies

Genomma Lab continued to lead dermatologicals in 2019, with its main brands including Medicasp, Lomecan and Unesia. Genomma Lab continued to run strong advertising campaigns, increasingly tapping into the social media channel.

Players increasingly target social media for their advertising

A number of players were continuing to use social media as a major advertising and promotional channel at the end of the review period. For example, Genomma Lab’s Lomecan in vaginal antifungals again benefited from a strong campaign and presence on social networks.

Private label remains underdeveloped

Private label remains undeveloped in dermatologicals. Only topical antifungals and topical germicidals/antiseptics have a private label presence, but, even in these categories, branded products continued to dominate value sales.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in Colombia

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Colombia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Colombia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Colombia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Colombia?
  • What are the major brands in Colombia?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in Colombia - Category analysis

HEADLINES

PROSPECTS

Antifungals and haemorrhoid treatments losing their social stigma?
Increasing diagnosis of skin diseases offers growth potential for dermatologicals
Venezuelan immigrants provide a major new consumer base for products like nappy (diaper) rash treatments

COMPETITIVE LANDSCAPE

Dermatologicals led by foreign companies
Players increasingly target social media for their advertising
Private label remains underdeveloped

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
Table 6 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in Colombia - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to grow in 2019
Smuggling remains a problem for the consumer health market in Colombia
GSK Consumer Healthcare the clear leader, with foreign companies leading most categories
Chemists/pharmacies still the leading distribution channel
Increasing awareness of self-care and an ageing population will help drive sales

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 9 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2014-2019
Table 11 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 12 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 13 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format: % Value 2014-2019
Table 16 Distribution of Consumer Health by Format and Category: % Value 2019
Table 17 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2018-2019

DEFINITIONS

SOURCES

Summary 2 Research Sources